Kendte CYP3A induktorer såsom rifampicin, carbamazepin og andre induktoreraf P450 cytokromer forventes derfor ikke at have signifikant virkning på den aktive metabolits farmakokinetik.
Therefore, known CYP3A inducers such as rifampicin, carbamazepine, and other inducers of cytochromes P450 are not anticipated to have significant effect on the pharmacokinetics of the active metabolite.